Metraipolis › archive › dc_fc8193829d8a

Immunogenicity of SARS-CoV-2 vaccine prototype based on virus-like particles of hepatitis B core antigen from genotype G and interleukin 12 expressing Semliki… — Europe PMC PMID:41785011

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41785011
DOI
10.1099/jgv.0.002240
License (as archived)
solo-consultazione
Archived
2026-11-05T11:35:42.598Z
SHA-256 of the archived text
4f847c98110fd12ad4e9795e995a73388c964886220c0db6658066b0470161af
Stable URL of this page
https://metraipolis.com/documento/dc_fc8193829d8a

How to cite

Immunogenicity of SARS-CoV-2 vaccine prototype based on virus-like particles of hepatitis B core antigen from genotype G and interleukin 12 expressing Semliki… — Europe PMC PMID:41785011 — Europe PMC (en), https://europepmc.org/article/MED/41785011 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc8193829d8a (Metraipolis archive dc_fc8193829d8a, sha256 4f847c98110fd12ad4e9795e995a73388c964886220c0db6658066b0470161af)
BibTeX
@misc{dcfc8193829d8a,
  title = {Immunogenicity of SARS-CoV-2 vaccine prototype based on virus-like particles of hepatitis B core antigen from genotype G and interleukin 12 expressing Semliki… — Europe PMC PMID:41785011},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41785011},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc8193829d8a; sha256 4f847c98110fd12ad4e9795e995a73388c964886220c0db6658066b0470161af},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41785011. Agents can read the archived copy with the MCP tool read_document.